Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | PRNP | P04156 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.54 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | ELANE | P08246 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14721112 | 0.87 | LMNA (0.54) | LMNAL3MBTL1TDP1ALDH1A1HPGD | |
| SCHEMBL6421307 | 0.86 | ALDH1A1 (0.54) | LMNAL3MBTL1TDP1ALDH1A1HPGD | |
| SCHEMBL3162185 | 0.85 | L3MBTL1 (0.60) | LMNAL3MBTL1ALDH1A1HPGDMAPT | |
| SCHEMBL1686764 | 0.84 | NPC1 (0.52) | LMNAL3MBTL1TDP1ALDH1A1HPGD | |
| SCHEMBL2302836 | 0.84 | KMT2A (0.50) | LMNAL3MBTL1TDP1ALDH1A1HPGD | |
| SCHEMBL17785160 | 0.83 | LMNA (0.50) | LMNAL3MBTL1TDP1ALDH1A1HPGD | |
| SCHEMBL9373019 | 0.82 | ALDH1A1 (0.61) | L3MBTL1TDP1ALDH1A1HPGDPRNP | |
| SCHEMBL7329978 | 0.82 | ALDH1A1 (0.56) | LMNAL3MBTL1TDP1ALDH1A1HPGD | |
| SCHEMBL7344673 | 0.82 | ALDH1A1 (0.61) | LMNAL3MBTL1TDP1ALDH1A1HPGD | |
| SCHEMBL2300941 | 0.82 | ALDH1A1 (0.52) | LMNAL3MBTL1TDP1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116603117-B | Super-hydrophobic drug structure coating with drug release performance and preparation method thereof | 四川大学华西医院 | 2023-10-13 | — | — | CN | claimed |
| CN-116603117-A | Super-hydrophobic drug structure coating with drug release performance and preparation method thereof | 四川大学华西医院 | 2023-08-18 | — | — | CN | claimed |
| US-20240018081-A1 | METHOD FOR PRODUCING ORGANIC FLUORINE COMPOUNDS | DAIKIN INDUSTRIES, LTD. (JP) | 2024-01-18 | — | — | US | disclosed |
| CN-116603117-B | Super-hydrophobic drug structure coating with drug release performance and preparation method thereof | 四川大学华西医院 | 2023-10-13 | — | — | CN | disclosed |
| CN-116603117-A | Super-hydrophobic drug structure coating with drug release performance and preparation method thereof | 四川大学华西医院 | 2023-08-18 | — | — | CN | disclosed |
| EP-4089203-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING ORGANIC COMPOUND | Daikin Industries, Ltd. (JP) | 2022-11-16 | — | — | EP | disclosed |
| US-20220341045-A1 | METHOD FOR PRODUCING FLUORINE-CONTAINING ORGANIC COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2022-10-27 | — | — | US | disclosed |
| EP-3372589-B1 | PYRIMIDINE DERIVATIVE | ASKA PHARM CO LTD (JP) | 2021-10-20 | — | — | EP | disclosed |
| CN-111808003-A | Preparation method of thioether | 甘肃农业大学 | 2020-10-23 | — | — | CN | disclosed |
| US-9855260-B2 | Quinolinone derivatives | GLAXOSMITHKLINE LLC (US) | 2018-01-02 | — | — | US | disclosed |
| WO-2017073709-A1 | PYRIMIDINE DERIVATIVE | あすか製薬株式会社 | 2017-05-04 | — | — | WO | disclosed |
| US-4588732-A | Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors | CIBA-GEIGY CORPORATION (US) | 1986-05-13 | — | — | US | disclosed |
| US-4556666-A | INSECTICIDES | ROUSSEL UCLAF (FR) | 1985-12-03 | — | — | US | disclosed |
| US-4539410-A | THROMBOXANE SYNEHETASE INHIBITORS | CIBA-GEIGY CORPORATION (US) | 1985-09-03 | — | — | US | disclosed |
| US-4536505-A | THROMBOXANE SYNTHETASE INHIBITOR, ANTIISCHEMIC, ANTIARRHYTHMIA, ANTIINFLAMMATORY AND HYPOTENSIVE AGENTS | CIBA-GEIGY CORPORATION (US) | 1985-08-20 | — | — | US | disclosed |
| US-4511573-A | THROMBOXANE SYNTHETASE INHIBITORS | CIBA-GEIGY CORPORATION (US) | 1985-04-16 | — | — | US | disclosed |
| US-4478842-A | THROMBOXANE SYNTHETASE INHIBITORS | CIBA-GEIGY CORPORATION (US) | 1984-10-23 | — | — | US | disclosed |
| US-4470986-A | ISCHEMIA, SHOCK, THROMBOSIS | CIBA-GEIGY CORPORATION (US) | 1984-09-11 | — | — | US | disclosed |
| EP-0107618-A1 | N-substituted-2-(1-imidazolyl)-indoles | CIBA-GEIGY AG (CH) | 1984-05-02 | — | — | EP | disclosed |
| US-4444775-A | ENZYME INHIBITORS | CIBA-GEIGY CORPORATION (US) | 1984-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018081-A1 | METHOD FOR PRODUCING ORGANIC FLUORINE COMPOUNDS | PFAS, FBL, FLNB | LMNA 2377/4885L3MBTL1 3706/4885TDP1 566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.